Qatar Biobank Builds Momentum Thursday, May 23, 2013 Qatar Biobank recently welcomed its 300th participant through the doors of its centre in Hamad Medical City. Cell Therapy Catapult to work with GSK on Cell Therapies Wednesday, May 22, 2013 First partnership with large pharma company for Cell Therapy Catapult. UK-Norwegian Collaboration Aims to Develop a New Living Skin Equivalent Model Tuesday, May 21, 2013 New in vitro human living skin equivalent model for testing inflammatory responses. FDA Agreement on Mesoblast’s Use of Singapore Manufacturing Facility for MPCs Clinical Trial Production Tuesday, May 21, 2013 New facility will support product delineation strategies, increase geographical reach, and reduce risk of single site reliance. Program for Breakthrough Biomedical Research to Celebrate 15 Years Tuesday, May 21, 2013 A program that fosters basic science projects of potentially high impact is celebrating 15 years of discovery at UC San Francisco. UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice Friday, May 17, 2013 Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. Team Successfully Converts Human Skin Cells into Embryonic Stem Cells Friday, May 17, 2013 The breakthrough marks the first time human stem cells have been produced via nuclear transfer and follows several unsuccessful attempts by research groups worldwide. Nobel Prize Rockets Stem Cell Program to New Heights Thursday, May 16, 2013 Shinya Yamanaka's Feat Brings fresh attention to promise of regeneration medicine. Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients Thursday, May 16, 2013 In addition, a second Phase 2 trial of MPCs as a first-line biologic treatment for active RA is planned to commence in Europe in 1H 2013.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 1780 |
|
|